The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

In pharma, buying software (instead of building) means working with industry professionals who can develop solutions to meet ...

Pharmaceutical companies breathed a sigh of relief on Wednesday, but the tariff reprieve could prove fleeting.

Steinkühler: AI presents a tremendous opportunity in the field of finance, primarily because it facilitates the use and ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

Medical marketers, ad agencies, physicians and pharma executives gathered for MM+M’s annual Transform conference, held at One ...

Massive cuts at the FDA have hit staff tied to drug reviews and user fees, putting future approvals in jeopardy, according to ...

End-to-end automation could offer significant benefits: speed, accuracy, and scalability. Digital workers perform repetitive ...

Pharmaceutical exports from Ireland to the United States could face punitive tariffs "within the next few weeks," according ...

The industry needs to embrace innovation with technology towards novel drug development to remain relevant in the marketplace.